Candel Therapeutics, Inc. (CADL) vs Pharming Group N.V. Sponsored ADR (PHAR)
- Candel Therapeutics, Inc. CADL 8.19 −8.08%
- Pharming Group N.V. Sponsored ADR PHAR 9.36 −2.80%
Candel Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. Candel Therapeutics, Inc. and Pharming Group N.V. Sponsored ADR are of similar size ($681.8M and $681.6M). Candel Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 62.4×. Pharming Group N.V. Sponsored ADR grew revenue faster over the last twelve months: 7.85% against 0.00%. Pharming Group N.V. Sponsored ADR has the higher net margin (2.55% vs 0.00%) and the higher return on invested capital (5.50% vs 0.00%). Across the 18 metrics below, Pharming Group N.V. Sponsored ADR leads on 16 and Candel Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | CADL | PHAR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 86.54% | 65.16% |
| Operating margin | 0.00% | 5.04% | 0.00% |
| Net margin | 0.00% | 2.55% | 0.00% |
| Free cash flow margin | 0.00% | 9.38% | 0.00% |
| Return on equity | (81.84%) | 3.67% | (56.36%) |
| Return on assets | (56.37%) | 2.05% | (48.04%) |
| Return on invested capital | 0.00% | 5.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack